Dopamine D3 receptor ligands or antagonists for use in the treatment of renal function disorders

US7098214B1 · kind B1 · utility

Assignee

• Abbott GmbH & Co. KG · DE

Inventors

• Bernd Mühlbauer · Rottenburg am Neckar, DE
• Gerhard Max Gross · Beerse, BE
• Dorothea Starck · Ludwigshafen, DE
• Hans-Jörg Treiber · Münstermaifeld, DE

Key dates

• Filing date: Apr 28, 2000
• Grant date: Aug 29, 2006
• Expiry date: Apr 28, 2020

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Dopamine D3 receptor ligands or antagonists are disclosed for use in the treatment of renal function disorders, such as diabetic nephropathy.